News

For 10 years, the AODstats data site has delivered up-to-date evidence that informs life-saving decisions on alcohol and other drug policies and planning.

One of the highest honours in Australian health and medical sciences, election to the Australian Academy of Health and Medical Sciences (AAHMS) recognises Professor Lumban as one of the nation’s most outstanding minds in health and medical research, innovation and leadership.

Smartphone-based cognitive training could become an accessible and effective addition to standard treatment for alcohol use disorder.

Thanks to the 2025 Frank Murphy Travelling Scholarship, Dr Hall presented at one of the world’s biggest international conferences in health economics.

Exploring the intersection of stress and addiction in women’s mental health

Thanks to a $1.97 million MRFF grant, Monash University researchers are set to launch a large-scale, multidisciplinary project that takes a contemporary approach to preventing substance use and mental health problems.

Thank you to all who have been part of our story for the past 30 years! Since 1995, Turning Point has been at the forefront of responding to health reforms, delivering high-quality services, and shaping the conversation on addiction.

Master of Addictive Behaviours graduate Nic Robinson-Griffith has published his award-winning thesis on transgender and gender diverse inclusion in AOD residential treatment.

A new report is shedding light on the relationship between sleep quality, sleep-wake cycle patterns, and methamphetamine use disorder in women.

Don’t miss the new podcast from JOY Media's ‘Well Well Well’ with Turning Point and Thorne Harbour Health

We’re delighted to announce that Professor Victoria Manning has secured $1.9 million in funding from the National Health and Medical Research Council and the Ramsay Hospital Research Foundation to lead an innovative trial set to transform alcohol treatment for thousands of Australians.

The 2025 Margaret Hamilton Travelling Scholarship recipient presented findings from an open-label pilot study of oxytocin for methamphetamine withdrawal in women.